Some medications are designed so that the metabolite the substance created after phase I metabolism is actually the active drug
acarbose can be added to these measures in patients with hypoglycemia In patients who have not responded to initial therapy, (slow-release) somatostatin analogs are the treatment of choice In patients with treatment-refractory dumping syndrome, surgical reinterventions or continuous enteral feeding can be considered, but the outcomes of such approaches are variable This is a preview of subscription content, access via your institution Access options Subscribe to this journal Receive 12 print issues and online access $189.00 per year only $15.75 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF
On the other hand, it has also been suggested that pancreatic-derived GLP-1 may play a role even under normal circumstances
The department said it is also reviewing six additional submissions for generic semaglutide products from other manufacturers and expects to make more regulatory decisions in the coming weeks and months
Perfect B | 8200 NW 41st St, Suite 100, Doral, FL 33166 (786) 502-2260 Explore our Peptide Treatment Plan at Perfect B in Doral, FL and see which protocol fits your goals.
Martinon, F